öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÏÄÔÆÁú
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º35

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Ö÷Òª½øÐз¿ÐÔÐÄÂÉʧ³££¨°üÀ¨ÐÄ·¿²ü¶¯£©µÄ·¢Éú»úÖÆÓëµ¼¹ÜÏûÈÚÖÎÁÆÑо¿£¬ÐÄÁ¦Ë¥½ßÓëÐĵçʧͬ²½¡¢ÐÄ... [Õ¹¿ª]


Ñо¿ÁìÓò£º Ö÷Òª½øÐз¿ÐÔÐÄÂÉʧ³££¨°üÀ¨ÐÄ·¿²ü¶¯£©µÄ·¢Éú»úÖÆÓëµ¼¹ÜÏûÈÚÖÎÁÆÑо¿£¬ÐÄÁ¦Ë¥½ßÓëÐĵçʧͬ²½¡¢ÐÄÊҷʺñ¡¢ÐÄÊÒÏËά»¯»úÖÆÑо¿£¬ÐÄÁ¦Ë¥½ßµÄÊÒÐÔ¶ñÐÔÐÄÂÉʧ³£µÄ·¢Éú»ù´¡¼°ÁÙ´²Ô¤¾¯Ñо¿µÈ¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºyunlong_xia@126.com


¸öÈ˼òÊö :
ÏÄÔÆÁú£¬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½Ôº¸±Ôº³¤£¬´óÁ¬Ò½¿Æ´óѧÐÄѪ¹Ü²¡Ò½ÔºÔº³¤¡£1996Äê±ÏÒµÓÚÖйúÒ½¿Æ´óѧ£»2001Äê»ñµÃ´óÁ¬Ò½¿Æ´óѧ˶ʿѧλ£»2007ÄêÓÚÈðµä¡µÂ´óѧÐÄÔà¿Æ»ñµÃ²©Ê¿Ñ§Î»¡£ÆÚ¼äÏȺ󸰵¹úºº±¤Óë·¨¹ú²¨¶û¶àеçÉúÀíÖÐÐĶÌÆÚ½»Á÷ѧϰ¡£³¤ÆÚ´ÓÊÂÐÄÔàÆð²«ÓëµçÉúÀí¹¤×÷ÒÔ¼°Ñо¿£¬ÓÈÆäÉ󤸴ÔÓÐÄÂÉʧ³£ÒÔ¼°ÐÄ·¿²ü¶¯µÄµ¼¹ÜÏûÈÚÊõ¡¢ÐÄÁ¦Ë¥½ßÐÄÊÒÔÙͬ²½»¯ÖÎÁÆÒÔ¼°â§ËÀÔ¤·ÀµÈ¡£ÏȺó°ïÖúÈ«¹ú¸÷µØ¶à¼ÒÈý¼×¼¶ÒÔÉÏÒ½Ôº¿ªÕ¹Ïà¹Ø¼¼Êõ²Ù×÷¡£ÏÖΪÖлªÒ½Ñ§»áÐÄÔàÆð²«ÓëµçÉúÀí·Ö»áÇàÄêίԱ»á¸±Ö÷ÈÎίԱ£¬ÐĵçÉúÀíѧ×é³ÉÔ±£»ÐÄ·¿²ü¶¯¹¤×÷×é³ÉÔ±£»ÊÒÐÔÐÄÂÉʧ³£Î¯Ô±»áίԱ£»ÖлªÒ½Ñ§»áÐÄѪ¹Ü²¡Ñ§·Ö»áÇàÄêίԱ£¬ÖлªÒ½Ñ§»áÐÄѪ¹Ü²¡Ñ§·Ö»áÐÄÂÉʧ³£Ñ§×é³ÉÔ±£¬ÖлªÒ½Ñ§»áÐÄѪ¹Ü²¡Ñ§·Ö»á¾«×¼Ò½Ñ§Ñ§×é³ÉÔ±£»ÖйúҽʦЭ»áÐÄѪ¹Ü²¡·Ö»áÐÄÂÉʧ³£Î¯Ô±»áίԱ£»ÖйúҽʦЭ»áÐÄÁ¦Ë¥½ß·Ö»áÇàÄêίԱ»á¸±Ö÷ÈÎίԱ£»ÁÉÄþʡҽѧ»áÐÄѪ¹Ü²¡Ñ§·Ö»á¸±Ö÷ÈÎίԱ£»ÁÉÄþʡҽѧ»áÐĵçÉúÀíÓëÆ𲫷ֻáίԱ³£Î¯£»ÁÉÄþʡҽʦЭ»áÀíÊ£»ÁÉÄþʡҽʦЭ»á×éÖ¯¹¤×÷ίԱ»áίԱ£»´óÁ¬ÊÐҽѧ»áÐĵçÉúÀíÓëÆ𲫷ֻḱÖ÷ÈÎίԱ£»´óÁ¬ÊÐҽѧ»á¿ÆÑйÜÀí·Ö»á¸±Ö÷ÈÎίԱ¡£ÎÀÉú²¿¹ú¼ÒҽѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÖÐÐÄר¼Ò×é³ÉÔ±£»ÎÀÉú²¿½éÈëÕïÁÆ×ÊÖÊÐÄÂÉʧ³£Åàѵµ¼Ê¦£»¹ú¼Ê¶¯Ì¬ÐĵçͼÓëÎÞ´´Ðĵçѧ£¨International Society for Holter and Noninvasive Electrocardiology, ISHNE£© ¶­Ê»á³ÉÔ±¡£¹ú¼ÊÐÄÔಡѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÆÚ¿¯Cardiology Journal ÔÓÖ¾¸±Ö÷±à£¨Associateeditor£©, Journal of Innovations in Cardiac Rhythm Management ÔÓÖ¾£¬Cardiovascular Diagnosis and Therapy ÔÓÖ¾±àί£¬Journal of Thoracic Disease ±àί¡£

¿ÆÑй¤×÷ :
ÏȺóÖ÷³Ö3Ïî¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬2ÏîÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£¬Ö÷³Ö1ÏîÁÉÄþÊ¡¸ßµÈѧУ½Ü³öÇàÄêѧÕ߳ɳ¤¼Æ»®ÏîÄ¿£¬1ÏîÁÉÄþÊ¡½ÌÓýÌü¿Æ¼¼¼Æ»®ÏîÄ¿£¬Ö÷³Ö´óÁ¬ÊпƼ¼¾Ö¿Æ¼¼×¨Ïî2Ïî¡£·¢±íSCIÎÄÕÂ30Óàƪ£¬µÚÒ»×÷Õß/ͨѶ×÷Õß12ƪ¡£ÏȺó»ñµÃÁÉÄþÊ¡Õþ¸®¿Æ¼¼½ø²½Ò»µÈ½±1Ï¶þµÈ½±2Ïî¡£´óÁ¬ÊпƼ¼½ø²½Ò»µÈ½±1Ïî¡£
ÔÚÑÐÏîÄ¿
1. ·ºËػøE1´Ù½øÐÄ·¿Öع¹¼°²ü¶¯·¢ÉúµÄ·Ö×Ó»úÖÆ£¨**£©£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2015/8/1-2019/12/31£¬60Íò£¬Ö÷³Ö
2. Àë×ÓͨµÀ·ºËØ»¯ÐÞÊε÷½ÚȱѪÐÔÐÄÁ¦Ë¥½ß²¢·¢¶ñÐÔÐÄÂÉʧ³£·Ö×Ó»úÖÆÑо¿£¨2014E14SF172£©£¬´óÁ¬ÊпÆѧ¼¼Êõ»ù½ð¼Æ»®ÏîÄ¿£¬2014/12/1-20016/12/31,5Íò£¬Ö÷³Ö
3. ÐÄ·¿²ü¶¯»¼ÕßȱѪÐÔÄÔ×äÖеÄ×ۺϷÀÖÎÑо¿£¨LNCCC-B04-2014£©£¬ÁÉÄþÊ¡ÎÀÉú¼ÆÉúίÌáÉýÁÙ´²ÕïÁÆÄÜÁ¦½¨ÉèÏîÄ¿£¬2014/09/23-2017/12/31,100Íò£¬Ö÷³Ö
4. Ò»Ñõ»¯µªºÏ³Éø1ת½Óµ°°×£¨NOS1AP£©·ºËØÐÞÊε÷½ÚÊÒÐÔÐÄÂÉʧ³£·Ö×Ó»úÖÆÑо¿£¨**£©£¬ÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð£¬2014/07/19-2016/12/31,5Íò£¬Ö÷³Ö
5. ȱѪÐÔÐÄÁ¦Ë¥½ßÐÄÊÒÕûÌ帴¼«ÀëÉ¢Óë¿ç±Ú¸´¼«ÀëÉ¢µÄÈýάµ¥Ïò¶¯×÷µçλÑо¿£¨**£©£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2012/08/17 -2016/12/31, 55Íò£¬Ö÷³Ö
5. 4q25»ùÒò¶à̬ÐÔÓëÐÄ·¿²ü¶¯×¨¹ÜÏûÈڳɹ¦ÂʹØϵµÄÑо¿£¨2011JHDW019£©£¬´óÁ¬ÊпƼ¼¾ÖÏîÄ¿£¬2011/09/01-2013/12/01,5Íò£¬Ö÷³Ö
6. 4q25»ùÒò¶à̬ÐÔÓëÐÄ·¿²ü¶¯×¨¹ÜÏûÈڳɹ¦ÂʹØϵµÄÑо¿£¬ÁÉÄþÊ¡½ÌÓýÌü¹úÓÅÐãÈ˲ÅÖ§³Ö¼Æ»®£¬2012/1/1-2014/12/31£¬6Íò£¬Ö÷³Ö
7. Pitx2»ùÒò¶à̬ÐÔÓëÐÄ·¿²ü¶¯µ¼¹ÜÏûÈڳɹ¦ÂʹØϵµÄÑо¿¡£ÁÉÄþÊ¡¸ßµÈѧУ½Ü³öÇàÄêѧÕ߳ɳ¤¼Æ»®ÏîÄ¿£¬ 2012.01-2014.12¡£10Íò£¬Ö÷³Ö
8. ÐÄÁ¦Ë¥½ß·¢Éú¶ñÐÔÊÒÐÔÐÄÂÉʧ³£µÄÈýάµ¥Ïò¶¯×÷µçλÑо¿£¨**£©£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÀ࣬2008/09/01-2011/12/31£¬21Íò£¬Ö÷³Ö
´ú±íÎÄÕÂ
1.Chen F, Yang Y, Zhang R, Zhang S, DongY, Yin X, Chang D, Yang Z, Wang K, Gao L, Xia Y. Polymorphism rs** atchromosome 4q25 is associated with atrial fibrillation recurrence afterradiofrequency catheter ablation in the Chinese Han population. Am J TranslRes. 2016 Feb 158(2):688-697£¨Í¨Ñ¶×÷Õߣ©IF=3.402
2.Wang X, Wang HX, Li YL, Zhang CC, ZhouCY, Wang L, Xia YL*, Du J*, Li HH*. MicroRNA Let-7i negatively regulatescardiac inflammation and fibrosis. Hypertension. 2015 Oct66(4):776-85. (ͨѶ×÷Õß) IF=6.48
3.Li WJ, Liu Y, Wang JJ, Zhang YL, Lai S,XiaYL, Wang HX, Li HH. Angiotensin II memory contributes to thedevelopment of hypertension and vascular injury via activation of NADPHoxidase. Life Sci. 2016 Mar 15149:18-24.IF=2.702
4.Dang MQ, Zhao XC, Lai S, Wang X, WangL, Zhang YL, Liu Y, Yu XH, Liu Y, Li HH*, Xia YL*. Gene expression profile inthe early stage of angiotensin II-induced cardiac remodeling: a time seriesmicroarray study in a mouse model. Cell Physiol Biochem. 201535(2):467-76. (ͨѶ×÷Õß)IF=2.875
5.Zhao WJ, Wei SN, Zeng XJ, XiaYL, Du J, Li HH. Gene expression profiling identifies the novel role ofimmunoproteasome in doxorubicin-induced cardiotoxicity. Toxicology. 2015 Jul 3333:76-88. IF=3.6216.Han QY, Wang HX, Liu XH, Guo CX, Hua Q,Yu XH, Li N, Yang YZ, Du J, Xia YL*, Li HH*. Circulating E3ligases are novel and sensitive biomarkers for diagnosis of acute myocardialinfarction. ClinSci (Lond). 2015Jun128(11):751-60. (ͨѶ×÷Õß)IF=5.598
7.Li N, Wang HX, Han QY, Li WJ, Zhang YL,Du J, Xia YL*, Li HH*. Activation of the cardiac proteasome promotesangiotension II-induced hypertrophy by down-regulation of ATRAP. J Mol CellCardiol. 2015 ,79:303-314. £¨Í¨Ñ¶×÷Õߣ©IF=4.655
8.Wang AW, Song L, Miao J, Wang HX, TianC, Jiang X, Han QY, Yu L, Liu Y, Du J, Xia YL*, Li HH*. Baicaleinattenuates angiotensin II-induced cardiac remodeling via inhibition ofAKT/mTOR, ERK1/2, NF-¦ÊB, and calcineurin signaling pathways in mice. Am JHypertens. 2015 Apr28(4):518-26. (ͨѶ×÷Õß)IF=2.852
9.Zhang JS, Zhang YL, Wang HX, XiaYL, Wang L, Jiang YN, Li HH, Liu Y. Identification of genes related tothe early stage of Angiotensin II-induced acute renal injury by microarray andintegrated gene network analysis. Cell Physiol Biochem. 201434(4):1137-51.IF=2.875
10. Wang T, Xia YL*, Zhang SL, GaoLJ, Xie ZZ, Yang YZ, Zhao J*. The impact of hypertension on theelectromechanical properties and outcome of catheter ablation in atrialfibrillation patients. J Thorac Dis. 2014 Jul6(7):913-20. (ͨѶ×÷Õß)IF=1.783